Tempest Therapeutics, Inc. (TPST)

Last Closing Price: 0.31 (2026-11-18)

Income from Continuous Operations (Quarterly)

Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.

Tempest Therapeutics, Inc. (TPST) had Income from Continuous Operations of $-3.63M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-3.63M
--
--
$2.82M
$-2.82M
$-0.81M
$-3.63M
$-3.63M
$-3.63M
Income from Continuous Operations
$-3.63M
$-3.63M
$-3.63M
$-2.82M
$-2.77M
16.91M
16.91M
$-0.21
$-0.21
Balance Sheet Financials
$1.61M
$0.43M
$7.15M
$8.76M
$4.67M
--
$5.92M
$10.59M
$-1.83M
$-1.83M
$-1.83M
16.89M
Cash Flow Statement Financials
$-12.43M
$0.00M
$5.62M
$7.71M
$0.90M
$-6.81M
$0.16M
--
--
Fundamental Metrics & Ratios
0.34
--
--
--
--
--
--
--
--
--
--
$-12.43M
--
--
--
--
--
--
--
198.30%
198.31%
-41.42%
198.31%
$-0.11
$-0.73
$-0.73